Laura Galli

8.8k total citations
298 papers, 5.3k citations indexed

About

Laura Galli is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Laura Galli has authored 298 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Infectious Diseases, 98 papers in Virology and 65 papers in Epidemiology. Recurrent topics in Laura Galli's work include HIV Research and Treatment (96 papers), HIV/AIDS drug development and treatment (92 papers) and HIV/AIDS Research and Interventions (57 papers). Laura Galli is often cited by papers focused on HIV Research and Treatment (96 papers), HIV/AIDS drug development and treatment (92 papers) and HIV/AIDS Research and Interventions (57 papers). Laura Galli collaborates with scholars based in Italy, United States and United Kingdom. Laura Galli's co-authors include Adriano Lazzarin, Antonella Castagna, Nicola Gianotti, Antonio E. Pontiroli, Karl C. Podratz, Armando D’Angelo, Maurice J. Webb, Andrea Mariani, Ferruccio Fazio and Paolo Rama and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

In The Last Decade

Laura Galli

284 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Galli Italy 35 1.3k 1.1k 948 736 588 298 5.3k
Joan Skurnick United States 42 575 0.4× 744 0.7× 755 0.8× 249 0.3× 633 1.1× 108 6.7k
Michael F. Schneider United States 37 869 0.7× 858 0.8× 386 0.4× 187 0.3× 697 1.2× 95 6.7k
Vivek Jain United States 29 543 0.4× 526 0.5× 514 0.5× 340 0.5× 482 0.8× 118 4.3k
Michael Væth Denmark 47 456 0.4× 1.3k 1.1× 245 0.3× 424 0.6× 704 1.2× 173 7.9k
Douglas S. Ross United States 46 943 0.7× 1.2k 1.1× 393 0.4× 998 1.4× 2.2k 3.8× 115 9.4k
Carmine Tinelli Italy 59 1.3k 1.0× 3.9k 3.4× 657 0.7× 1.1k 1.5× 2.3k 4.0× 419 12.7k
Claus Henrik Nielsen Denmark 43 672 0.5× 545 0.5× 440 0.5× 422 0.6× 379 0.6× 267 6.6k
Cheryl Enger United States 41 273 0.2× 876 0.8× 280 0.3× 222 0.3× 522 0.9× 109 5.7k
Giorgio Pardi Italy 42 679 0.5× 683 0.6× 276 0.3× 73 0.1× 377 0.6× 141 5.7k
Alan R. Cohen United States 36 421 0.3× 540 0.5× 249 0.3× 150 0.2× 529 0.9× 119 7.1k

Countries citing papers authored by Laura Galli

Since Specialization
Citations

This map shows the geographic impact of Laura Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Galli more than expected).

Fields of papers citing papers by Laura Galli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Galli. The network helps show where Laura Galli may publish in the future.

Co-authorship network of co-authors of Laura Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Galli. A scholar is included among the top collaborators of Laura Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Galli. Laura Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galli, Laura & Prannoy Suraneni. (2025). Durability and damage resistance of sustainable Portland limestone cement-based (ultra) high-performance concrete in seawater. Materials and Structures. 58(9). 310–310.
2.
Montagnani, Carlotta, et al.. (2025). Pediatric central line-associated bloodstream infections management: A retrospective study. American Journal of Infection Control. 54(4). 376–381.
3.
Galli, Laura, Roberta Gagliardini, Filippo Lagi, et al.. (2024). Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ Open. 14(2). e080606–e080606. 6 indexed citations
4.
Raccagni, Angelo Roberto, Laura Galli, Martina Ranzenigo, et al.. (2024). Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian Cohort. Sexually Transmitted Diseases. 51(8). 540–544. 4 indexed citations
5.
Canetti, Diana, Laura Galli, Silvia Nozza, et al.. (2023). Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice. Drug Design Development and Therapy. Volume 17. 3697–3706. 2 indexed citations
6.
Margalit, Ili, Giusy Tiseo, Marco Ripa, et al.. (2023). Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study. Journal of Antimicrobial Chemotherapy. 78(6). 1505–1509. 5 indexed citations
7.
Candela, Caterina, Laura Galli, Alberto Rizzo, et al.. (2023). Mpox DNA clearance in semen over 6‐month follow‐up. Journal of Medical Virology. 95(12). e29259–e29259. 4 indexed citations
8.
Bonato, Matteo, Filippo Turrini, Maria Francesca Piacentini, et al.. (2023). Failure of Digital Device Performance in Monitoring Physical Exercise in a Pilot Study in Sedentary Persons with HIV. Sensors. 23(23). 9461–9461. 1 indexed citations
9.
Spagnuolo, Vincenzo, Laura Galli, Andrea Poli, et al.. (2022). Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study. Drug Design Development and Therapy. Volume 16. 3645–3654. 3 indexed citations
10.
Morsica, Giulia, Laura Galli, Emanuela Messina, et al.. (2022). Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients. Journal of Oncology. 2022. 1–10. 5 indexed citations
11.
Gagliardini, Roberta, Patrizia Lorenzini, Alessandro Cozzi‐Lepri, et al.. (2022). Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures. Journal of Global Antimicrobial Resistance. 32. 158–163. 5 indexed citations
12.
Nozza, Silvia, Angelo Roberto Raccagni, Laura Galli, et al.. (2022). Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort. BMJ Open. 12(12). e067261–e067261. 6 indexed citations
13.
Galli, Laura, et al.. (2018). Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat.. PubMed. 41(4). 256–261. 9 indexed citations
14.
15.
Bona, Anna De, et al.. (2007). Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy.. PubMed. 30(3). 259–64. 6 indexed citations
16.
Piana, Federica, Luigi Ruffo Codecasa, Laura Galli, et al.. (2006). Comparison of an In-house and a Commercial RD1-based ELISPOT-IFN-  Assay for the Diagnosis of Mycobacterium tuberculosis Infection. Clinical Medicine & Research. 4(4). 266–272. 15 indexed citations
17.
Bagaglio, Sabrina, Raffaele Bruno, S. Lodrini, et al.. (2004). Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.. PubMed. 17(2). 153–61. 9 indexed citations
18.
Marchesoni, Antonio, et al.. (1999). Psoriatic arthritis in British and Italian patients: a comparative clinical, radiologic, and scintigraphic study.. PubMed. 26(12). 2619–21. 5 indexed citations
19.
Troiano, P., et al.. (1997). The preservation of the ocular surface during chronic administration of hypotensive eye drops. Orbit. 16. 87–90. 1 indexed citations
20.
Galli, Laura, et al.. (1997). LASER PHOTOCOAGULATION OF CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS. Retina. 17(1). 12–16. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan Skurnick Breakdown of academic impact, for papers by Michael F. Schneider Breakdown of academic impact, for papers by Vivek Jain Breakdown of academic impact, for papers by Michael Væth Breakdown of academic impact, for papers by Douglas S. Ross Breakdown of academic impact, for papers by Carmine Tinelli Breakdown of academic impact, for papers by Claus Henrik Nielsen Breakdown of academic impact, for papers by Cheryl Enger Breakdown of academic impact, for papers by Giorgio Pardi Breakdown of academic impact, for papers by Alan R. Cohen
Rankless by CCL
2026